Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioXcel Therapeutics (BTAI) Times Interest Earned (2022 - 2025)

BioXcel Therapeutics (BTAI) has 4 years of Times Interest Earned data on record, last reported at -$3.62 in Q3 2025.

  • For Q3 2025, Times Interest Earned rose 10.32% year-over-year to -$3.62; the TTM value through Sep 2025 reached -$3.3, up 32.85%, while the annual FY2024 figure was -$4.59, 64.45% up from the prior year.
  • Times Interest Earned reached -$3.62 in Q3 2025 per BTAI's latest filing, up from -$3.75 in the prior quarter.
  • Across five years, Times Interest Earned topped out at -$2.77 in Q1 2025 and bottomed at -$4497.1 in Q1 2022.
  • Average Times Interest Earned over 4 years is -$309.04, with a median of -$6.7 recorded in 2024.
  • The widest YoY moves for Times Interest Earned: up 99.62% in 2023, down 79.21% in 2023.
  • A 4-year view of Times Interest Earned shows it stood at -$15.3 in 2022, then skyrocketed by 71.13% to -$4.42 in 2023, then skyrocketed by 33.34% to -$2.94 in 2024, then decreased by 22.94% to -$3.62 in 2025.
  • Per Business Quant database, its latest 3 readings for Times Interest Earned were -$3.62 in Q3 2025, -$3.75 in Q2 2025, and -$2.77 in Q1 2025.